Clinical Trial Update: Concentrated Citrate Locking to Reduce the Incidence of CVC-related Complications in Hematological Patients [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating whether concentrated citrate locking reduces central venous catheter-related complications in hematological patients has been termina…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacteremia
• Hematological Malignancies
• Thrombosis

Drugs mentioned

• Concentrated citrate locking solution (citrate lock solution)

Snippet

Sponsor: Maastricht University Medical Center | Conditions: Hematological Malignancies, Bacteremia | Phase 3 | Status: TERMINATED